Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

Disorders Stocks Recent News

Date Stock Title
May 9 CPRX HHS panel to vote in Nov. on DMD screening for newborns
May 9 CPRX Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript
May 9 ELDN Eledon Pharmaceuticals GAAP EPS of -$0.34 beats by $0.04
May 9 FULC Fulcrum Therapeutics to Participate in Upcoming May Conferences
May 9 ELDN Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
May 9 ELDN Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
May 8 CPRX Catalyst Pharmaceuticals Non-GAAP EPS of $0.38 beats by $0.08, revenue of $98.44M misses by $0.33M
May 8 CPRX Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
May 8 FULC Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology
May 8 BAX Baxter International First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 8 BAX Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff
May 7 CPRX Catalyst Pharmaceuticals Q1 2024 Earnings Preview
May 7 BAX Baxter to Present at Bank of America 2024 Health Care Conference
May 7 BAX Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
May 7 CGTX Cognition Therapeutics GAAP EPS of -$0.27
May 7 CGTX Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
May 7 ELDN Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
May 7 ELDN Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
May 6 FULC Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET
May 3 BAX Baxter International Inc. (NYSE:BAX) Q1 2024 Earnings Call Transcript
Disorders

Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

Browse All Tags